Testing patient’s blood for two proteins or biomarkers that occur when inflammation is present could help doctors identify which patients are more likely to have a stroke, according to a new article in the journal Stroke.
Testing patient’s blood for two proteins or biomarkers that occur when inflammation is present could help doctors identify which patients are more likely to have a stroke, according to a new article in the journal Stroke.